Anish Suri
2022
In 2022, Anish Suri earned a total compensation of $1.2M as President and Chief Scientific Officer at Cue Biopharma.
Compensation breakdown
| Bonus | $148,572 |
|---|---|
| Option Awards | $525,674 |
| Salary | $489,832 |
| Other | $3,576 |
| Total | $1,167,654 |
Suri received $525.7K in option awards, accounting for 45% of the total pay in 2022.
Suri also received $148.6K in bonus, $489.8K in salary and $3.6K in other compensation.
Rankings
In 2022, Anish Suri's compensation ranked 2,741st out of 5,760 executives tracked by ExecPay. In other words, Suri earned more than 52.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,741 out of 5,760 | 52nd |
Division Manufacturing | 1,523 out of 3,136 | 51st |
Major group Chemicals And Allied Products | 703 out of 1,422 | 51st |
Industry group Drugs | 655 out of 1,323 | 51st |
Industry Pharmaceutical Preparations | 473 out of 969 | 51st |
Source: SEC filing on April 26, 2024.
Suri's colleagues
We found two more compensation records of executives who worked with Anish Suri at Cue Biopharma in 2022.